These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 10342946)

  • 1. No value of oral clodronic acid in malignant osteolysis.
    Prescrire Int; 1998 Aug; 7(36):104. PubMed ID: 10342946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of bisphosphonate for the palliative treatment of painful bone metastasis due to hormone refractory prostate cancer.
    Heidenreich A; Hofmann R; Engelmann UH
    J Urol; 2001 Jan; 165(1):136-40. PubMed ID: 11125382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].
    Tubiana-Hulin M; Beuzeboc P; Mauriac L; Barbet N; Frenay M; Monnier A; Pion JM; Switsers O; Misset JL; Assadourian S; Bessa E
    Bull Cancer; 2001 Jul; 88(7):701-7. PubMed ID: 11495824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metastatic bone lesions in solid tumors and possible use of clodronate (Bonephos) in clinical oncology].
    Moiseenko VM; Blinov NN
    Vopr Onkol; 1996; 42(2):17-30. PubMed ID: 8815629
    [No Abstract]   [Full Text] [Related]  

  • 5. Intravenous pamidronic acid: new indications. Useful palliative treatment for osteolysis.
    Prescrire Int; 1998 Aug; 7(36):103-5. PubMed ID: 10342945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate cancer and bone metastases. The effect of clodronate.
    Kylmälä T
    Ann Chir Gynaecol; 1998; 87(1):59-60. PubMed ID: 9598233
    [No Abstract]   [Full Text] [Related]  

  • 7. Clodronate in the management of bone metastases: a clinical study of 91 patients.
    Serkies K; Jereczek-Fossa B; Badzio A; Jassem J
    Neoplasma; 1999; 46(5):317-22. PubMed ID: 10665850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of bisphosphonates can dramatically improve pain in advanced hormone-refractory prostate cancer patients.
    Rodrigues P; Hering F; Campagnari JC
    Prostate Cancer Prostatic Dis; 2004; 7(4):350-4. PubMed ID: 15534620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Double-blind trial of oral clodronate in breast cancer patients with bone metastases].
    Paterson AH; Powles TJ; Kanis JA; McCloskey E; Hanson J; Ashley S
    Bull Cancer; 1993; 80(10 Suppl):50-6. PubMed ID: 8081032
    [No Abstract]   [Full Text] [Related]  

  • 10. [An experience with combined therapy of radiation and Bonephos for osteolytic metastases of breast cancer].
    Poliakov PIu; Larionova NA; Bychenkov OA; Moc'kin VG
    Vopr Onkol; 1999; 45(3):311-3. PubMed ID: 10443239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of hormone-refractive prostatic carcinoma with painful bone metastasis. Epirubicin vs. clodronate vs. epirubicin plus clodronate].
    Heidenreich A
    Urologe A; 1997 Nov; 36(6):568. PubMed ID: 9487597
    [No Abstract]   [Full Text] [Related]  

  • 12. The analgesic efficacy of clodronate compared with placebo in patients with painful bone metastases from prostatic cancer.
    Strang P; Nilsson S; Brändstedt S; Sehlin J; Borghede G; Varenhorst E; Bandman U; Borck L; Englund G; Selin L
    Anticancer Res; 1997; 17(6D):4717-21. PubMed ID: 9494595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Randomized trial of two administration schedule of bonephos (Clodronate) in patients with painful bone metastasis].
    Moiseenko VM; Blinov NN; Semiglazov VV; Konstantinova MM; Trishkina EA
    Vopr Onkol; 1998; 44(6):725-8. PubMed ID: 10087976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dichloromethylene diphosphonate (Cl2MDP) treatment of hypercalcaemia produced from bone metastases (author's transl)].
    Delmas P; Chapuy MC; Vignon E; Briançon D; Charhon S; Meunier PJ
    Nouv Presse Med; 1982 Apr; 11(19):1471-4. PubMed ID: 6210878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of bisphosphonates in palliative treatment of bone metastases in a terminally ill, oncological elderly population.
    Santangelo A; Testai M; Barbagallo P; Manuele S; Di Stefano A; Tomarchio M; Trizzino G; Musumeci G; Panebianco P; Maugeri D
    Arch Gerontol Geriatr; 2006; 43(2):187-92. PubMed ID: 16325938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of clodronic acid in mineral metabolism conditions: state of the art in 2000].
    Brandi ML
    Minerva Med; 2001 Aug; 92(4):251-68. PubMed ID: 11535969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.
    Ernst DS; Tannock IF; Winquist EW; Venner PM; Reyno L; Moore MJ; Chi K; Ding K; Elliott C; Parulekar W
    J Clin Oncol; 2003 Sep; 21(17):3335-42. PubMed ID: 12947070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of visible bone metastases by clodronate therapy in breast cancer.
    Tjalma WA; Buytaert PM; Berneman ZN
    Eur J Gynaecol Oncol; 2001; 22(3):215-6. PubMed ID: 11501775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clodronate prevents prosthetic migration: a randomized radiostereometric study of 50 total knee patients.
    Hilding M; Ryd L; Toksvig-Larsen S; Aspenberg P
    Acta Orthop Scand; 2000 Dec; 71(6):553-7. PubMed ID: 11145380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.